Agilon HealthAGL +0.27%74 ROA % is 14.10% as of Mar. 2026. GuruFocus rates AGL with a GF Score™ of 74/100 and a GF Value™ of $94.48 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 686 Healthcare Providers & Services companies, Agilon Health ranks worse than 83.38% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Agilon Health's annualizedNet Income for the quarter that ended in Mar. 2026 was $196 Mil.
Agilon Health's average Total Assets over the quarter that ended in Mar. 2026 was $1,388 Mil. Therefore, Agilon Health's annualized ROA % for the quarter that ended in Mar. 2026 was 14.10%.
The historical rank and industry rank for Agilon Health's ROA % or its related term are showing as below:
AGL'
s ROA % Range Over the Past 10 Years
Min: -70.16 Med: -15.27 Max: -6.49
Current: -22.11
During the past 7 years, Agilon Health's highest ROA % was -6.49%. The lowest was -70.16%. And the median was -15.27%.
AGL's ROA % is ranked worse than 83.38% of 686
companies
in the Healthcare Providers & Services industry
Industry Median: 1.75
vs AGL: -22.11
Agilon Health (NYSE:AGL) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Agilon Health ROA % Related Terms
Agilon Health ROA % Historical Data
* Premium members only.
The historical data trend for Agilon Health's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Agilon Health's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Agilon Health ROA % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Agilon Health's ROA % distribution charts can be found below:
* The bar in red indicates where Agilon Health's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Agilon Health (AGL) has a ROA % of 14.10% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Agilon Health and its competitors. According to the industry distribution chart, Agilon Health ranks #572 out of 686 companies in the Healthcare Providers & Services industry, placing it in the top 83.4%.
Is Agilon Health's ROA % too high?
Agilon Health's current ROA % is 14.10%. The Healthcare Providers & Services industry median ROA % is 1.75. Agilon Health's value of 14.10% is 705.7% above this industry median. Based on the distribution chart, Agilon Health ranks #572 out of 686 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Agilon Health has a GF Score™ of 74/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Agilon Health's ROA % compare to AVAH and HCSG?
According to the Healthcare Providers & Services industry distribution chart, Agilon Health ranks #572 out of 686 companies for ROA %. This places Agilon Health in the lower half of its industry. The industry median ROA % is 1.75. Agilon Health's value of 14.10% is 705.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Healthcare Providers & Services company?
The median ROA % among Healthcare Providers & Services companies is 1.75, based on 686 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Agilon Health's current ROA % of 14.10% is 705.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Agilon Health and its competitors. For the Healthcare Providers & Services industry, the median ROA % is 1.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Agilon Health's current ROA % is 14.10%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Agilon Health stock overvalued right now?
Based on GuruFocus' analysis, Agilon Health (AGL) is currently considered Modestly Overvalued. The stock's GF Value™ is $94.48, compared to a current price of $107.25 — trading 13.5% above its estimated fair value. The current ROA % is 14.10% and 705.7% above the Healthcare Providers & Services industry median of 1.75. Agilon Health's overall GF Score™ is 74/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Agilon Health (AGL), the current ROA % is 14.10% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Agilon Health (AGL) Overvalued in 2026?
Based on GuruFocus' analysis, Agilon Health stock appears to be overvalued.
The current stock price of $107.25 is trading 13.5% above its estimated GF Value™ of $94.48.
GuruFocus considers Agilon Health to be Modestly Overvalued.
Key valuation signals for AGL:
ROA %: 14.10%
GF Value™: $94.48 vs. price of $107.25 (13.5% above fair value)
Industry Position: 705.7% above the Healthcare Providers & Services median (#572 of 686)
No single metric tells the full story. See the AGL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Agilon Health Inc is a healthcare services company that partners with primary care physicians to support value-based care for senior patients. The company provides a platform that enables physician groups to manage healthcare outcomes and costs through a Medicare-centric, capitated care model and long-term partnerships with community-based physicians.
74GF Score
Get the complete analysis for AGL
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AGL has been successfully added to your 
